Abstract

Melatonin 2-mg/mL Oral Suspension

Author(s): Allen Loyd V Jr

Issue: Nov/Dec 2016 - Volume 20, Number 6

Page(s): 512

Download in electronic PDF format for $75
  • Melatonin 2-mg/mL Oral Suspension Page 1

Abstract

A formulation for preparing Melatonin 2-mg/mL Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • melatonin
  • central nervous system agents
  • CNS depressant
  • antioxidant
  • circadian rhythm disturbances
  • sleep disorders
  • jet lag
  • delayed sleep phase syndrome
  • rapid eye movement sleep behavior disorder
  • insomnia
  • high blood pressure
  • hypertension
  • pain relief
  • analgesic
  • endogenous hormone
  • medicinal plant

Related Categories

  • FORMULATIONS
  • PAIN MANAGEMENT
  • CARDIOLOGY
  • ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE
  • NEUROLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Nov/Dec 2016
Pg. 512
Melatonin 2-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Jan/Feb 2022
Pg. 18-23
A Compendium of Compounding Agents and Formulations, Part 1: Melatonin
Author(s): Riepl Mike
May/Jun 2011
Pg. 246
Melatonin 1-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Jul/Aug 2001
Pg. 310-312
Wetting and/or Solubilizing Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
May/Jun 2010
Pg. 182-192
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
Jan/Feb 2020
Pg. 62
Progesterone 100-mg, Melatonin 1-mg, and L-Theanine 200-mg Slow-Release Capsules
Author(s): Allen Loyd V Jr
Jan/Feb 2010
Pg. 10-13
Sleepless in America: Compounding with Melatonin
Author(s): Wynn Tom, Rawlings Kate
Sep/Oct 2021
Pg. 414
Clonidine 0.01-mg/mL in Ora-Blend Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2022
Pg. 6-8
Compounded Melatonin Cream for the Prevention and Treatment of Radiation Dermatitis: A Case Report
Author(s): Garcia-Segura Laura Corral, Garcia-Segura Javier Corral, Delgado Carlos Dorado, Maldonaldo Nuria Romero, Salgado Elena Cardero, Llorens Lucía Pérez
Sep/Oct 2021
Pg. 417
Haloperidol 0.5-mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Jul/Aug 2013
Pg. 270-280
Jet Injection Devices for the Needle-free Administration of Compounds, Vaccines, and Other Agents
Author(s): Logomasini Mark A, Stout Richard R, Ron Marcinkoski
Jan/Feb 2010
Pg. 40-45
Diverse Challenges in Pediatric Compounding: Treating Pulmonary Hypertension, Uncombable Hair Syndrome, and Acanthamoeba keratitis
Author(s): Muller George, Young Thomas W, Reina Rachel, Caldwell Delmar R
Nov/Dec 2009
Pg. 506-515
Autologous Eye Drops for the Treatment of Dry Eye and Neurotrophic Keratitis
Author(s): Mixon William, Angelle Patricea (Patsy), Chang Richard I
Jan/Feb 2004
Pg. 46-48
Basics of Compounding for Disorders of the External Ear
Author(s): Allen Loyd V Jr
Sep/Oct 2021
Pg. 415
Dapsone 2-mg/mL in Oral Mix or Oral Mix SF Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2020
Pg. 38-43
Basics: Excipients Used in Nonsterile Compounding, Part 4: Antioxidants and Chelating Agents
Author(s): Allen Loyd V Jr
Jul/Aug 2021
Pg. 325
Hydrocortisone 2-mg/mL in Oral Mix Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2014
Pg. 418-426
Stability and In Vitro Toxicity of an Infliximab Eye Drop Formulation
Author(s): Robert Marie-Claude, Spurr-Michaud Sandra, Frenette Mathieu, Young David, Gipson Ilene K, Dohlman Claes H